Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

163.17 -0.73 (-0.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 770,771
Open 163.06
Bid (Size) 162.50 (100)
Ask (Size) 172.00 (200)
Prev. Close 163.90
Today's Range 160.99 - 166.43
52wk Range 100.99 - 175.77
Shares Outstanding 55,679,964
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Repligen (NASDAQ:RGEN) Combines Strong Growth with a Promising Technical Breakout Setup ↗
Via Chartmill
News headline image
Why Repligen (RGEN) Stock Is Up Today
What Happened? Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 14.6% in the afternoon session after the company reported ... 
Via StockStory
Topics Artificial Intelligence

Performance

YTD
-0.7%
-0.7%
1 Month
+12.6%
+12.6%
3 Month
+40.8%
+40.8%
6 Month
+13.6%
+13.6%
1 Year
+45.8%
+45.8%

More News

Read More
News headline image
Repligen Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Which stocks are gapping on Tuesday? ↗
Via Chartmill
Repligen (NASDAQ:RGEN) Rallies as Quality Stock Delivers Earnings Beat ↗
Via Chartmill
Repligen Corp (NASDAQ:RGEN) Sees Pre-Market Gain After Q1 Earnings Beat Offsets Slight Revenue Miss ↗
Via Chartmill
Topics Earnings
News headline image
Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q2 CY2026
Via StockStory
News headline image
Repligen (RGEN) Q2 Earnings: What To Expect
Via StockStory
News headline image
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know
Via StockStory
News headline image
3 Cash-Producing Stocks That Concern Us
Via StockStory
News headline image
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach ↗
Via MarketBeat
News headline image
Why Repligen (RGEN) Stock Is Trading Lower Today
Via StockStory
News headline image
3 Reasons RGEN is Risky and 1 Stock to Buy Instead
Via StockStory
Topics Stocks Supply Chain
News headline image
2 High-Flying Stocks on Our Watchlist and 1 We Find Risky
Via StockStory
News headline image
2 Profitable Stocks on Our Watchlist and 1 Facing Challenges
Via StockStory
News headline image
3 Out-of-Favor Stocks We Keep Off Our Radar
Via StockStory
News headline image
Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks
Via StockStory
News headline image
Why Repligen (RGEN) Stock Is Trading Up Today
Via StockStory
Topics Artificial Intelligence Economy
News headline image
1 Growth Stock with Explosive Upside and 2 Facing Headwinds
Via StockStory
News headline image
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy
News headline image
5 Revealing Analyst Questions From Repligen’s Q1 Earnings Call
Via StockStory
Topics Earnings
News headline image
3 Small-Cap Stocks We Steer Clear Of
Via StockStory
News headline image
Repligen (RGEN) Shares Skyrocket, What You Need To Know
Via StockStory
Topics Artificial Intelligence Earnings Regulatory Compliance
News headline image
Repligen (RGEN) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Repligen’s (NASDAQ:RGEN) Q1 CY2026 Sales Beat Estimates
Via StockStory
Topics Earnings

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 163.17
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 08/10/26 04:00 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 9.09B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.